Picture of Canntab Therapeutics logo

PILL Canntab Therapeutics Share Price

0.000.00%
ca flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Momentum

Relative Strength (%)
1m-67.68%
3m-76.1%
6m-69.98%
1yr-96.45%
Volume Change (%)
10d/3mn/a
Price vs... (%)
52w Highn/a
50d MAn/a
200d MAn/a

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capitaln/a
Return on Equityn/a
Operating Margin-6575.24%

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st May 202331st May 2024
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2023 / 2024

Blurred out image of Canntab Therapeutics EPS forecast chart

Profile Summary

Canntab Therapeutics Limited is a Canadian phytopharmaceutical company focused on the manufacturing and distribution of a suite of hard pill cannabinoid formulations in multiple doses and timed-release combinations. The Company’s operations comprise a single segment engaged in the medical marijuana business. The Company’s hard pill cannabinoid formulations provide doctors, patients, and consumers with medical grade solutions. These include once a day and extended-release formulations. Its products include INSTANT RELEASE - (IR Tablet), EXTENDED-RELEASE - (XR Tablet), and ORAL DISSOLVING - O.D. Tablet (ODT). The IR Tablet is a release profile for solid hard tablets. The XR Tablet is a phytocannabinoid vehicle that is designed to directly address the drawbacks and challenges of competing oral delivery systems. ODT is specifically designed to dissolve directly in the patient’s mouth, with an onset of action between five and thirty minutes.

Directors

Last Annual
May 31st, 2022
Last Interim
February 28th, 2023
Incorporated
July 30th, 2021
Public Since
April 21st, 2011
Sector
Pharmaceuticals
Industry
Healthcare
Exchange
ca flag iconCanadian Securities Exchange
Shares in Issue
38,909,159
Blurred out image of a map
Address
411 Cranbrooke Avenue, TORONTO, M4M 1N4
Web
Phone
Auditors
CLEARHOUSE LLP

PILL Share Price Performance

Similar to PILL

Picture of 1933 Industries logo

1933 Industries

ca flag iconCanadian Securities Exchange

Picture of 1CM logo

1CM

ca flag iconCanadian Securities Exchange

Picture of Acreage Holdings logo

Acreage Holdings

ca flag iconCanadian Securities Exchange

Picture of Adastra Holdings logo

Adastra Holdings

ca flag iconCanadian Securities Exchange

Picture of Aion Therapeutic logo

Aion Therapeutic

ca flag iconCanadian Securities Exchange

FAQ